Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.
about
BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1AML1 interconnected pathways of leukemogenesisImmunotherapy in acute leukemiaT-cell-based therapies for malignancy and infection in childhood.MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.Gene therapy for paediatric leukaemia.T-cell therapy of leukemia.Adoptive cellular therapy: a therapeutic reality?The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.Tumor-associated antigens: from discovery to immunity.Absence of leukaemic fusion gene transcripts in preterm infants exposed to diagnostic x raysImmunotherapy targets in pediatric cancer.Interferon alpha and T-cell responses in chronic myeloid leukemia.Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.Telomerase immunity from bench to bedside: round one.A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.Mobilizing the low-avidity T cell repertoire to kill tumors.Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes.Human Tumor Antigens and Cancer Immunotherapy.Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.Transplantation for Childhood Acute Lymphoblastic Leukemia
P2860
Q24806130-9FC9B38F-BF6F-465F-A567-D53D822E84C0Q28184349-87F15EAB-C4AE-4950-9507-99CFA030E1EAQ33731552-F6CFF073-CE93-40ED-A915-2700B5C2A576Q33750862-4C041434-8F4B-4ED1-A294-28C2ED6D907BQ34060270-53E8107C-238A-444F-8088-338E76E24C96Q34155839-09095098-B85C-4B9D-A1B6-E065976F826BQ34451905-22104E62-BA38-4266-9018-0024D2B0D82DQ34608658-371856DE-9F0D-4E8A-8B75-E5FB65FF73A0Q34875170-4C16F481-3FA4-4D8F-8E5C-601B74B25BE6Q35000726-1313586D-9555-452D-B244-90D5F8510F2AQ35214398-6C0A0B6F-9A65-420C-BBE3-13B2B4423308Q35293385-E7C9A42E-CC3F-4A13-94F5-DD40B901884BQ35971029-20FB734E-4C85-4FE0-9F45-E22F89C396FBQ35994924-E6DED46D-A00E-499E-86BE-4793DBF18FDCQ36369960-E2BA7C89-8B0A-4467-AF2C-EF34A406F486Q36662079-A9AFB86F-7258-4979-BCA3-6775E4FAF591Q36745749-0F2C067C-92FA-4553-B7BC-1B7D4BAFE8ABQ36813562-7E963794-6C95-4775-8CF6-7D4960CCFBC4Q36891310-E4FBA5EC-BAAB-41AF-8EE2-365BDA52C8DCQ37248354-930DCCE3-00A2-4204-9CB4-408F9AD1E2DEQ37851050-15C2FF0E-5D26-477B-B8E6-5A00E1D24C2FQ40661469-C93B8FF6-7EC2-4C4E-B2BF-05527DF01481Q40750584-B481EF9A-BF46-4569-8BA8-AF2A63B492B0Q41533232-E484FDD1-263F-4F4B-9827-DB17DB24EB48Q46171835-FA229C2D-D3A5-46ED-A27B-2BECCED3124BQ47133741-7FB6D408-D7E1-447B-A153-1DEFD632A7B2Q59094157-CAB6C68F-99DD-4778-A49B-7DE9D6D24EC9
P2860
Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.
@en
Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.
@nl
type
label
Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.
@en
Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.
@nl
prefLabel
Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.
@en
Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
Cytotoxic T cell response agai ...... acute lymphoblastic leukemia.
@en
P2093
Grandchamp B
Langlade-Demoyen P
Lemonnier F
Peuchmaur M
P2860
P304
P356
10.1172/JCI3126
P407
P577
1998-07-01T00:00:00Z